Shamrock Industrial Co Ltd
₹ 27.2
0.00%
05 Oct
- close price
About
Shamrock Industrial Company Ltd historically manufactured and traded pharmaceutical products but has remained non-operational for over a decade, with nil operating revenue through Q1 FY27. Following a change in control during 2025, it is pursuing blockchain and digital-asset activities and has proposed subsidiaries for energy, data-centre and computing infrastructure.[1] [2] [3]
Key Points
- Market Cap ₹ 14.8 Cr.
- Current Price ₹ 27.2
- High / Low ₹ 27.2 / 17.6
- Stock P/E
- Book Value ₹ 0.96
- Dividend Yield 0.00 %
- ROCE -102 %
- ROE -102 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 28.4 times its book value
- Company has low interest coverage ratio.
- Promoter holding is low: 30.5%
- Company has a low return on equity of -28.1% over last 3 years.
- Promoter holding has decreased over last 3 years: -12.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.04 | 3.42 | 0.06 | 0.09 | 3.66 | 0.22 | 0.32 | 0.31 | 0.13 | 0.15 | 0.13 | 1.12 | 1.10 | |
| Operating Profit | -0.04 | -3.42 | -0.06 | -0.09 | -3.66 | -0.22 | -0.32 | -0.31 | -0.13 | -0.15 | -0.13 | -1.12 | -1.10 |
| OPM % | -36.36% | ||||||||||||
| 0.00 | 1.54 | 0.00 | 0.03 | 3.37 | 0.00 | 0.01 | 0.10 | 0.00 | 0.11 | 0.00 | 0.03 | 0.03 | |
| Interest | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.04 | -2.04 | -0.06 | -0.06 | -0.29 | -0.22 | -0.31 | -0.21 | -0.13 | -0.04 | -0.13 | -1.09 | -1.07 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.04 | -2.04 | -0.06 | -0.06 | -0.29 | -0.22 | -0.31 | -0.21 | -0.13 | -0.04 | -0.13 | -1.09 | -1.07 | |
| EPS in Rs | -0.07 | -3.76 | -0.11 | -0.11 | -0.53 | -0.41 | -0.57 | -0.39 | -0.24 | -0.07 | -0.24 | -2.01 | -1.96 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -463% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 93% |
| 1 Year: | 55% |
| Return on Equity | |
|---|---|
| 10 Years: | -27% |
| 5 Years: | -19% |
| 3 Years: | -28% |
| Last Year: | -102% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 |
| Reserves | -4.61 | -2.38 | -2.44 | -2.50 | -2.79 | -3.01 | -3.32 | -3.53 | -3.66 | -3.70 | -3.82 | -4.91 |
| 8.83 | 4.51 | 4.54 | 4.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.64 | 0.09 | 0.10 | 0.10 | 0.38 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.02 | 1.15 | |
| Total Liabilities | 11.29 | 7.65 | 7.63 | 7.64 | 3.02 | 2.46 | 2.16 | 1.94 | 1.80 | 1.76 | 1.63 | 1.67 |
| 1.05 | 1.05 | 1.05 | 1.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 3.42 | 3.42 | 3.42 | 3.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 3.09 | 3.09 | 3.09 | 3.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.73 | 0.09 | 0.07 | 0.08 | 3.02 | 2.46 | 2.16 | 1.94 | 1.80 | 1.76 | 1.63 | 1.67 | |
| Total Assets | 11.29 | 7.65 | 7.63 | 7.64 | 3.02 | 2.46 | 2.16 | 1.94 | 1.80 | 1.76 | 1.63 | 1.67 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 4.32 | 0.00 | 0.00 | -8.61 | -0.56 | -0.31 | -0.34 | -0.04 | -0.04 | -0.13 | -1.04 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 10.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.79 | -0.03 | |
| 0.00 | -4.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.07 | |
| Net Cash Flow | 0.00 | -0.01 | 0.00 | 0.00 | 2.21 | -0.56 | -0.31 | -0.34 | -0.04 | -0.04 | -0.92 | 0.00 |
| Free Cash Flow | 0.00 | 4.32 | 0.00 | 0.00 | 2.39 | -0.56 | -0.31 | -0.34 | -0.04 | -0.04 | -0.13 | -1.04 |
| CFO/OP | 0% | -126% | 0% | 0% | 235% | 255% | 97% | 110% | 31% | 27% | 100% | 93% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | ||||||||||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | ||||||||||||
| Working Capital Days | ||||||||||||
| ROCE % | -21.85% | -0.80% | -0.80% | -71.91% | -8.70% | -13.69% | -10.47% | -7.08% | -2.29% | -7.78% | -102.35% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Years of Non-Operation years |
|
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- Board appointed NGMKS & Associates as statutory auditor on October 5, 2026 and approved postal ballot notice.
-
Board Meeting Outcome for Outcome Of Meeting Of The Board Of The Company Held On October 05, 2026.
- Board appointed NGMKS & Associates as statutory auditor on October 5, 2026; postal ballot approved.
-
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
- Motilal & Associates LLP resigned as statutory auditor effective September 30, 2026 due to pre-occupation.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2008
from bse
-
Annual Report 2007
from bse
-
Annual Report 2006
from bse
-
Annual Report 2005
from bse
Operating Status:[1]
The company historically manufactured and traded pharmaceutical products, including API contract manufacturing, but has conducted no operating business for over a decade.[2]